Male hypogonadism associated with advanced cancer: a systematic review (Q37764473)

22 August 2017

1 reference

title

Male hypogonadism associated with advanced cancer: a systematic review (English)

1 reference

22 August 2017

1 reference

1 reference

Antonio Vigano

1

1 reference

22 August 2017

Melissa Piccioni

2

1 reference

22 August 2017

Barbara Trutschnigg

3

1 reference

22 August 2017

Laura Hornby

4

1 reference

22 August 2017

Prosanto Chaudhury

5

1 reference

22 August 2017

Robert Kilgour

6

1 reference

22 August 2017

10 June 2010

1 reference

Lancet Oncology Commission

22 August 2017

1 reference

22 August 2017

11

1 reference

22 August 2017

7

1 reference

22 August 2017

679-684

1 reference

Androgens and the ageing male and female

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Androgen therapy in women: an Endocrine Society Clinical Practice guideline.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Hypogonadism in male patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Cachexia-anorexia-asthenia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Terminal cancer. duration and prediction of survival time

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Update on anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Hormone substitution in male hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Androgens in postmenopausal women: production, possible role, and replacement options

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Bone mineral density in survivors of childhood brain tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Hypogonadism and androgen deficiency symptoms in testicular cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Gonadal function in men with testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Carcinoma of the prostate: relationship of pretreatment hormone levels to survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Construct validation of the hospital anxiety and depression scale with clinical populations.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

The use and misuse of androgens

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970021-8

7 January 2021

10.1016/S1470-2045(10)70021-8

Identifiers

DOI

1 reference

22 August 2017

1 reference